XML 37 R32.htm IDEA: XBRL DOCUMENT
v3.20.1

Description of Business and Basis of Preparation - Additional Information (Detail) - USD ($) |  |  |  |  |  | 12 Months Ended
--- | --- | --- | --- | --- | --- | ---
Dec. 31, 2019 | Dec. 12, 2019 | Sep. 14, 2018 | Mar. 08, 2018 | Jun. 21, 2016 | Dec. 31, 2019 | Dec. 31, 2018
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Accumulated deficit | $ (271,428,000) |  |  |  |  | $ (271,428,000) | $ (217,718,000)
Cash and cash equivalents | 41,920,000 |  |  |  |  | 41,920,000 | 11,439,000
Short-term investments | 6,494,000 |  |  |  |  | 6,494,000 | 32,718,000
Shelf registration maximum equity offering price | $ 127,500,000 |  | $ 175,000,000 |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  |  | 13,198,075 |  |  |  |
Aggregate amount receivable upon exercise of warrants |  |  | $ 28,600,000 |  |  |  |
Warrants, expiration date |  |  | Mar. 14, 2019 |  |  |  |
Common stock issued, net of expenses (in shares) |  |  |  | 17,751,500 | 9,375,000 |  |
Common stock issued, net of expenses |  |  |  |  |  | $ 30,530,000 | $ 20,437,000
Option to Purchase Common Stock |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Options expiration date |  | 2020-01 |  |  |  |  |
Option to Purchase Common Stock | Maximum |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of options not exercised |  | 5,833,333 |  |  |  |  |
Common Stock |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Common stock issued, net of expenses (in shares) |  |  |  |  |  | 47,736,920 | 18,959,675
Common stock issued, net of expenses |  |  |  |  |  | $ 47,000 | $ 19,000
Series 1 Warrant |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  |  |  |  |  |  | 115,550
Warrants, expiration date |  |  |  | Mar. 14, 2019 |  |  |
Sales Agreement | Common Stock |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Shelf registration maximum equity offering price |  |  | $ 25,000,000 |  |  |  |
June 2016 Public Offering |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  |  | 4,218,750 |  |  |  |
Exercise price of warrants (in dollars per share) |  |  | $ 3.00 |  | $ 3.00 |  |
June 2016 Public Offering | Warrant liability | Maximum |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  |  |  |  | 4,218,750 |  |
March 2018 Public Offering |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  |  |  | 21,301,800 |  |  |
Common stock issued, net of expenses (in shares) |  |  |  | 17,751,500 |  |  |
Share price (in dollars per share) |  |  |  | $ 1.69 |  |  |
Common stock issued, net of expenses |  |  |  | $ 27,900,000 |  |  |
March 2018 Public Offering | Series 1 Warrant |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  |  | 13,198,075 |  |  |  |
Exercise price of warrants (in dollars per share) |  |  | $ 1.85 | $ 1.85 |  |  |
March 2018 Public Offering | Series 1 Warrant | Maximum |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  |  |  | 13,313,625 |  |  |
March 2018 Public Offering | Series 2 Warrant |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  |  | 7,988,175 |  |  |  |
Exercise price of warrants (in dollars per share) |  |  | $ 2.00 | $ 2.00 |  |  |
March 2018 Public Offering | Series 2 Warrant | Maximum |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  |  |  | 7,988,175 |  |  |
March 2018 Public Offering | Warrant liability | Maximum |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  |  |  | 21,301,800 |  |  |
December 2019 Public Offering |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  | 38,888,889 |  |  |  |  |
Exercise price of warrants (in dollars per share) |  | $ 1.10 |  |  |  |  |
Warrants, expiration date |  | Jun. 12, 2023 |  |  |  |  |
Common stock issued, net of expenses (in shares) |  | 38,888,889 |  |  |  |  |
Share price (in dollars per share) |  | $ 0.90 |  |  |  |  |
Common stock issued, net of expenses |  | $ 32,500,000 |  |  |  |  |
December 2019 Public Offering | Warrant liability | Maximum |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  | 38,888,889 |  |  |  |  |
Underwriters | Maximum |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Option to purchase shares of common stock |  | 5,833,333 |  |  |  |  |
Underwriters | Warrant liability |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] |  |  |  |  |  |  |
Number of warrants issued to purchase common stock (in shares) |  | 5,833,333 |  |  |  |  |
Number of warrants exercised |  | 5,833,333 |  |  |  |  |

X
- Definition Aggregate amount receivable upon exercise of warrants. + References No definition available. + Details
Name: | scyx_AggregateAmountReceivableUponExerciseOfWarrants
Namespace Prefix: | scyx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Class of warrant or right exercised. + References No definition available. + Details
Name: | scyx_ClassOfWarrantOrRightExercised
Namespace Prefix: | scyx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Class of warrant or right not exercised. + References No definition available. + Details
Name: | scyx_ClassOfWarrantOrRightNotExercised
Namespace Prefix: | scyx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Option to purchase shares of common stock. + References No definition available. + Details
Name: | scyx_OptionToPurchaseSharesOfCommonStock
Namespace Prefix: | scyx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Options expiration date. + References No definition available. + Details
Name: | scyx_OptionsExpirationDate
Namespace Prefix: | scyx_
Data Type: | xbrli:gYearMonthItemType
Balance Type: | na
Period Type: | duration

X
- Definition Organization consolidation and presentation of financial statements disclosure. + References No definition available. + Details
Name: | scyx_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems
Namespace Prefix: | scyx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Shelf registration, maximum equity offering price. + References No definition available. + Details
Name: | scyx_ShelfRegistrationMaximumEquityOfferingPrice
Namespace Prefix: | scyx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Warrants expiration date. + References No definition available. + Details
Name: | scyx_WarrantsExpirationDate
Namespace Prefix: | scyx_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CashAndCashEquivalentsAtCarryingValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(2)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of investment in debt security measured at amortized cost (held-to-maturity), classified as current. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=118954083&loc=d3e26626-111562 + Details
Name: | us-gaap_HeldToMaturitySecuritiesCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(23)(a)(4)) -URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 + Details
Name: | us-gaap_RetainedEarningsAccumulatedDeficit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=scyx_OptionToPurchaseCommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=scyx_SeriesOneWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=scyx_SalesAgreementProspectusMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=scyx_June2016PublicOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=scyx_March2018PublicOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=scyx_SeriesTwoWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=scyx_DecemberTwoThousandAndNineteenPublicOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |